Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of the Angiotensin Receptor Blocker Telmisartan on the Red Blood Cell Function and the Microcirculatory Perfusion

NCT00559286 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT00559286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of the Angiotensin Receptor Blocker Telmisartan on the Red Blood Cell Function and the Microcirculatory Perfusion
Lead sponsor
RWTH Aachen University
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2007
Completion date
January 31, 2009
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, diabetes mellitus type 2 irc or nir